Sarah M. Cockle

Multinational cohort study of mortality in patients with asthma and severe asthma.

R. Suruki, F. Albers, K. Verhamme, 2020, Respiratory medicine.

Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis

A. Ismaila, Sarah M. Cockle, E. Huisman, 2015, International journal of chronic obstructive pulmonary disease.

Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma.

H. Ortega, F. Albers, S. Yancey, 2017, Respiratory medicine.

Incidence, risk factors and re‐exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study

R. Suruki, F. Albers, K. Verhamme, 2019, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Mepolizumab improves work productivity, activity limitation, symptoms, and rescue medication use in severe eosinophilic asthma

F. Albers, D. Bratton, R. Alfonso-Cristancho, 2022, The clinical respiratory journal.

Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study

R. Suruki, F. Albers, H. Müllerová, 2018, The Journal of asthma : official journal of the Association for the Care of Asthma.

Clinical characteristics and burden of illness among adolescent and adult patients with severe asthma by asthma control: the IDEAL study

F. Albers, H. Müllerová, Sarah M. Cockle, 2019, The Journal of asthma : official journal of the Association for the Care of Asthma.

Impact of mepolizumab on work productivity and activity impairment in severe eosinophilic asthma

F. Albers, Sarah M. Cockle, N. Gunsoy, 2017 .